78% of FDA-approved NDAs and BLAs in 2020 included an RWE study.
Aetion conducted a systematic review of FDA approval documents to understand the role RWE plays in providing evidence of safety and/or effectiveness in regulatory decisions. This year’s eBook will guide you through when, where, and how RWE supported approvals in 2020.Learn More
Enhance your regulatory submissions with RWE.
Download the eBook
Learn about the role of RWE in FDA approvals.